Over the past 12 months, 10 insiders at INCYTE CORP filed 32 open-market SEC Form 4 transactions on INCY: 0 purchases worth $0 and 32 sales worth $43.4M. Insiders have been net sellers over this period. The most recent filing was on Jul 16, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 16, 26 | Mohamed Khairie IssaEVP, Head of U.S. Commercial | SELL | 1.1K | $115.01 | $126K |
| Jul 16, 26 | Steven H SteinCMO & Head of Late-Stage Dev. | SELL | 1.9K | $114.73 | $215K |
| Jul 15, 26 | Steven H SteinCMO & Head of Late-Stage Dev. | SELL | 28.2K | $113.05 | $3.2M |
| May 19, 26 | Paul J Clancy | SELL | 15.0K | $94.93 | $1.4M |
| Apr 17, 26 | Pablo J CagnoniPresident, Global Head of R&D | SELL | 18.7K | $96.50 | $1.8M |
| Mar 17, 26 | Pablo J CagnoniPresident, R&D | SELL | 18.7K | $94.24 | $1.8M |
| Feb 19, 26 | Pablo J CagnoniPresident, R&D | SELL | 18.7K | $100.91 | $1.9M |
| Jan 7, 26 | Mohamed Khairie IssaEVP, Head of US Oncology | SELL | 10.9K | $109.07 | $1.2M |
| Jan 5, 26 | Steven H SteinEVP & Chief Medical Officer | SELL | 15.6K | $101.70 | $1.6M |
| Dec 19, 25 | Thomas TrayPrincipal Accounting Officer | SELL | 2.8K | $100.00 | $277K |
| Dec 18, 25 | Thomas TrayPrincipal Accounting Officer | SELL | 600 | $98.25 | $59K |
| Dec 17, 25 | Michael James MorrisseyEVP, Head of Tech. Operations | SELL | 4.3K | $97.26 | $420K |
| Dec 16, 25 | Michael James MorrisseyEVP, Head of Tech. Operations | SELL | 53.2K | $97.42 | $5.2M |
| Dec 11, 25 | Patrick A MayesEVP & Chief Scientific Officer | SELL | 255 | $94.94 | $24K |
| Dec 10, 25 | Patrick A MayesEVP & Chief Scientific Officer | SELL | 5.6K | $95.58 | $531K |
| Dec 2, 25 | Steven H SteinEVP & Chief Medical Officer | SELL | 20.1K | $102.51 | $2.1M |
| Dec 1, 25 | Steven H SteinEVP & Chief Medical Officer | SELL | 2.6K | $102.96 | $263K |
| Nov 24, 25 | Thomas TrayPrincipal Accounting Officer | SELL | 600 | $103.00 | $62K |
| Nov 21, 25 | Thomas TrayPrincipal Accounting Officer | SELL | 169 | $102.00 | $17K |
| Nov 17, 25 | Sheila A. DentonEVP & General Counsel | SELL | 278 | $104.36 | $29K |
| Nov 10, 25 | Herve HoppenotDirector | SELL | 187.5K | $105.46 | $19.8M |
| Nov 5, 25 | Steven H SteinEVP & Chief Medical Officer | SELL | 5.2K | $102.20 | $535K |
| Nov 4, 25 | Sheila A. DentonEVP & General Counsel | SELL | 598 | $101.36 | $61K |
| Nov 3, 25 | Lee HeesonEVP, Head of Incyte Intl | SELL | 3.1K | $94.02 | $289K |
| Oct 15, 25 | Sheila A. DentonEVP & General Counsel | SELL | 277 | $85.13 | $24K |
| Oct 3, 25 | Sheila A. DentonEVP & General Counsel | SELL | 3.5K | $85.54 | $299K |
| Oct 2, 25 | Sheila A. DentonEVP & General Counsel | SELL | 599 | $87.65 | $53K |
| Sep 16, 25 | Sheila A. DentonEVP & General Counsel | SELL | 278 | $83.15 | $23K |
| Sep 2, 25 | Sheila A. DentonEVP & General Counsel | SELL | 598 | $84.97 | $51K |
| Aug 15, 25 | Sheila A. DentonEVP & General Counsel | SELL | 277 | $86.81 | $24K |
| Aug 4, 25 | Sheila A. DentonEVP & General Counsel | SELL | 598 | $75.77 | $45K |
| Jul 21, 25 | Steven H SteinEVP & Chief Medical Officer | SELL | 3.7K | $67.94 | $252K |
| Jul 16, 25 | Barry P FlannellyEVP & General Manager US | SELL | 1.3K | $68.36 | $92K |
| Jul 16, 25 | Vijay K IyengarEVP, GMAPPS | SELL | 983 | $68.36 | $67K |
| Jul 16, 25 | Sheila A. DentonEVP & General Counsel | SELL | 785 | $68.36 | $54K |
| Jul 15, 25 | Sheila A. DentonEVP & General Counsel | SELL | 3.3K | $69.86 | $233K |
| Jul 15, 25 | Barry P FlannellyEVP & General Manager US | SELL | 1.2K | $69.86 | $83K |
| Jul 15, 25 | Vijay K IyengarEVP, GMAPPS | SELL | 1.2K | $69.86 | $82K |
| Jul 14, 25 | Steven H SteinEVP & Chief Medical Officer | SELL | 15.0K | $68.47 | $1.0M |
| Jul 3, 25 | Barry P FlannellyEVP & General Manager US | SELL | 10.9K | $68.15 | $743K |
| Jul 3, 25 | Vijay K IyengarEVP, GMAPPS | SELL | 5.9K | $68.16 | $404K |
| Jul 2, 25 | Sheila A. DentonEVP & General Counsel | SELL | 599 | $68.61 | $41K |
| Jun 3, 25 | Sheila A. DentonEVP & General Counsel | SELL | 1.8K | $68.00 | $122K |
| Jun 2, 25 | Thomas TrayPrincipal Accounting Officer | SELL | 651 | $64.88 | $42K |
| May 30, 25 | Thomas TrayPrincipal Accounting Officer | SELL | 963 | $65.71 | $63K |
| Mar 14, 25 | Barry P FlannellyEVP & General Manager US | SELL | 19.1K | $67.88 | $1.3M |
| Mar 4, 25 | Sheila A. DentonEVP & General Counsel | SELL | 599 | $69.99 | $42K |
| Feb 26, 25 | Sheila A. DentonEVP & General Counsel | SELL | 9.6K | $74.08 | $709K |
| Jan 21, 25 | Steven H SteinEVP & Chief Medical Officer | SELL | 12.4K | $72.69 | $898K |
| Dec 16, 24 | Thomas TrayPrincipal Accounting Officer | SELL | 650 | $69.31 | $45K |
Over the past 12 months, insiders at INCYTE CORP filed 0 open-market purchases worth $0 and 32 sales worth $43.4M on INCY, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 16, 26.
10 different insiders at INCYTE CORP filed open-market SEC Form 4 transactions on INCY over the last 12 months.
InsiderTape plots every INCY insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every INCYTE CORP insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →